Labratz Latest

🧬 FDA Launches Bold Plan to Replace Animal Testing

The End of Animal Trials?
The FDA just unveiled a major move to phase out animal testing in drug development—starting with monoclonal antibodies.

What’s New:
Instead of animal models, the FDA will now encourage AI simulations, human cell lines, and organoids to predict drug safety and effectiveness. Companies using these New Approach Methodologies (NAMs) may even get faster reviews.

Why It Matters:

• ⚡ Speeds up approvals

• 💰 Lowers R&D costs

• 🧠 Improves human safety predictions

• 🐾 Saves thousands of lab animals

What’s Next:
A pilot program launches this year, with broader guidance updates to follow. The FDA is teaming up with NIH, VA, and more to make this a reality.